Application of non intubated intravenous anesthesia in pediatric implanted venous port implantation

Application of non intubated intravenous anesthesia in pediatric implanted venous port implantation: A prospective randomized controlled clinical trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200060384

Enrollment

Unknown

Registered

2022-05-30

Start date

2022-05-17

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pediatric tumor

Interventions

Experimental group:Esketamine

Control group:None

Eligibility

Sex/Gender

All

Age

0.5 Years to 10 Years

Inclusion criteria

Inclusion criteria: 1. Children who plan to undergo infusion port implantation; 2. ASA score II-III; 3. Age: 0.5-10 years old.

Exclusion criteria

Exclusion criteria: 1. Patient guardians do not agree to participate in clinical research; 2. The patient has experienced any of the following conditions before surgery: extreme malnutrition, anemia above moderate, use of sedative and analgesic drugs, acute respiratory infection within 2 weeks; or the following conditions are occurring: fever (body temperature >= 38 ?) ; 3. The patient has a clear history of tolerance or allergy to esketamine and propofol; 4. ASA grade III or above.

Design outcomes

Primary

Measure	Time frame
Recovery time;	—

Secondary

Measure	Time frame
Time out of recovery room;University of Michigan Sedation Scale, UMSS;	—

Countries

China

Contacts

Public ContactOuyang Handong

Sun Yat-sen University Cancer Center

ouyhd@sysucc.org.cn+86 15889989587

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026